This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Spotify: Face the Music (Update 2019)
Vroom, Govert; Sastre Boquet, IsaacCase SM-1685-EInformation Technologies, Innovation and Change, StrategyIn early 2019, Spotify announced an operating profit of $94 million for the fourth quarter of 2018. The world's largest streaming company was approaching profitability for the first time, after a decade of massive losses. Previously a staggering increase in revenue, which exceeded $5 billion at the end of 2018, had failed to get it out of the red. By the late 2010s, streaming had become the way to consume music, fueling the first global sustained...Starting at €8.20
-
Sustaining Competitive Advantage: Competitive Strategy
Ly, Bryan S.; Vroom, GovertTechnical Note SMN-679-EInnovation and Change, Leadership and People ManagementIn "Value Creation & Capture", we discussed how firms gain competitive advantage and create value by making choices and trade-offs, allowing them to capture more value than rivals, and hence, generate greater profit. This note focuses on the internal analysis of a firm, concentrating on how a firm can combat imitation by utilizing its unique resources, capabilities, and core competencies. This resource-based approach emphasizes that the key to pr...Starting at €8.20
-
Competitive dynamics: Competitive Strategy
Ly, Bryan S.; Vroom, GovertTechnical Note SMN-680-EInnovation and Change, Leadership and People ManagementThis technical note will discuss some of the main strategies firms employ in close competition with other firms and how game theory can be used to help shape a firm's competitive strategy.Starting at €8.20
-
Spotify: Face the Music - Teaching Note
Vroom, Govert; Sastre Boquet, IsaacTeaching Note SMT-104-EStrategyStarting at €0.00
-
Competitive dynamics
Ly, Bryan S.; Vroom, GovertTechnical Note SMN-680Innovation and Change, Leadership and People ManagementEn la presente nota técnica se comentarán algunas de las principales estrategias que emplean las compañías con una gran rivalidad con otras empresas y cómo la teoría de juegos se puede utilizar para dar forma a la estrategia competitiva de las organizaciones.Starting at €8.20
-
Spotify: Face the Music (Update 2018) - Teaching Note: Seeking Profitability
Sastre Boquet, Isaac; Vroom, GovertTeaching Note SMT-119-EInformation Technologies, Innovation and Change, StrategySpotify reached $3 billion in revenues in 2016, amid a booming music-streaming market that now made up 51% of the U.S. music industry's total revenues. Finally the industry had embraced digitization and was now seeing two-digit growth for the first time in decades. However, that growth had an Achilles' heel. Spotify itself was staring at an operating loss of $350 million, having never been able to post a profit in all its years of existence. Now,...Starting at €0.00
-
Spotify: Face the Music (Update 2016) - Teaching Note: Facing Increased Competition
Sastre Boquet, Isaac; Vroom, GovertTeaching Note SMT-112-EStrategyThe case describes the business model of the music streaming company Spotify, setting it against the backdrop of a music industry that had faced steep revenue declines since the advent of digital formats in the late 1990s and the rise of illegal file sharing. The case also presents the competition Spotify faces from the likes of Pandora, Google and Apple and asks whether Spotify has a viable long-term business model despite its explosive user and...Starting at €0.00
-
New Immuno-Oncology Solutions (NIOS): Aligning Stakeholders in the Biotech Industry
Vroom, Govert; Maribel Berges; Sastre Boquet, IsaacCase SM-1701-EEntrepreneurship, Innovation and Change, StrategyThis case focuses on a small biotech company (NIOS), located in Barcelona, Spain, that is developing a new immune-oncology product for treating pancreatic cancer. The drug that the company is developing has recently finished Phase I of clinical trials successfully and is now preparing for Phase II and III. At this point, the CEO is approached by her former PhD director, a university professor, who asks if the company is interested in licensing a ...Starting at €8.20
-
Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story
Hamermesh, Richard G.; Kucherlapati, Raju; Gordon, RachelCase HBS-810066-EEntrepreneurshipIn May 2007, Amgen Inc. (Amgen) received disappointing news from the European Medicines Agency (EMEA) that its drug Vectibix, developed to fight metastatic colorectal cancer, had been rejected. This was especially surprising news given that a similar rival drug had received approval several years prior. Moreover, Vectibix had also received Food and Drug Administration approval in 2006. During additional trials, Amgen has learned that the Vectibix...Starting at €8.20
-
Pinkerton (B) (Spanish Version)
Mason, Scott P.; Lawrence, Elizabeth R.; Berger, Adam S.Case HBS-210S17FinanceEl director general de Pinkerton, una empresa de servicio de guardia de seguridad, está considerando opciones para alterar la estructura de capital restrictiva y costosa actual de la empresa. Una recapitulación de apalancamiento y la oferta pública inicial se consideran.Starting at €5.74